Augmentation of regulatory B cell activity in experimental allergic encephalomyelitis by glatiramer acetate

Journal of Neuroimmunology

Volumn 232, Issue 1-2, 2011, Pages 136-144

  Begum Haque, Sakhina ^a   Christy, Marc ^a   Ochoa Reparaz, Javier ^a   Nowak, Elizabeth C ^a   Mielcarz, Daniel ^a   Haque, Azizul ^a   Kasper, Lloyd H ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

B cells; CD19; CD5; Glatiramer acetate; Inflammation

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CD19 ANTIGEN; CD5 ANTIGEN; CHEMOKINE RECEPTOR CXCR5; GLATIRAMER;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; B LYMPHOCYTE; CELL MIGRATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DOWN REGULATION; DRUG EFFICACY; FEMALE; HUMORAL IMMUNITY; IMMUNOREGULATION; INFLAMMATORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT RESPONSE;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD19; ANTIGENS, CD5; B-LYMPHOCYTE SUBSETS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL SEPARATION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; FLOW CYTOMETRY; IMMUNOSUPPRESSIVE AGENTS; MICE; MICE, INBRED C57BL; PEPTIDES; RECEPTORS, CXCR5; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 79952280456     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.10.031     Document Type: Article

References (48)

1. Aharoni R., Teitelbaum D., Leitner O., Meshorer A., Sela M., Arnon R. Specific Th2 cells accumulate in the central nervous system of mice protected against experimental autoimmune encephalomyelitis by copolymer 1. Proc. Natl Acad. Sci. USA 2000, 97:11472-11477.
2. Aharoni R., Teitelbaum D., Sela M., Arnon R. Copolymer 1 induces T cells of the T helper type 2 that crossreact with myelin basic protein and suppress experimental autoimmune encephalomyelitis. Proc. Natl Acad. Sci. USA 1997, 94:10821-10826.
3. Aharoni R., Teitelbaum D., Sela M., Arnon R. Bystander suppression of experimental autoimmune encephalomyelitis by T cell lines and clones of the Th2 type induced by copolymer 1. J. Neuroimmunol. 1998, 91:135-146.
4. Arnon R., Aharoni R. Neurogenesis and neuroprotection in the CNS-fundamental elements in the effect of Glatiramer acetate on treatment of autoimmune neurological disorders. Mol. Neurobiol. 2007, 36:245-253.
5. Arnon R., Sela M. Immunomodulation by the copolymer glatiramer acetate. J. Mol. Recognit. 2003, 16:412-421.
6. Bar-Or A. The immunology of multiple sclerosis. Semin. Neurol. 2008, 28:29-45.
7. Bar-Or A., Oger J., Gibbs E., Niino M., Aziz T., Renoux C., Alatab S., Shi F.D., Campagnolo D., Jalili F., Rhodes S., Yamashita T., Fan B., Freedman M.S., Panitch H., Arnold D.L., Vollmer T. Serial combination therapy: is immune modulation in multiple sclerosis enhanced by initial immune suppression?. Mult. Scler. 2009, 15:959-964.
8. Begum-Haque S., Sharma A., Christy M., Lentini T., Ochoa-Reparaz J., Fayed I.F., Mielcarz D., Haque A., Kasper L.H. Increased expression of B cell-associated regulatory cytokines by glatiramer acetate in mice with experimental autoimmune encephalomyelitis. J. Neuroimmunol. 2010, 219:47-53.
9. Begum-Haque S., Sharma A., Kasper I.R., Foureau D.M., Mielcarz D.W., Haque A., Kasper L.H. Downregulation of IL-17 and IL-6 in the central nervous system by glatiramer acetate in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 2008, 204:58-65.
10. Bettelli E., Das M.P., Howard E.D., Weiner H.L., Sobel R.A., Kuchroo V.K. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J. Immunol. 1998, 161:3299-3306.
11. Bouaziz J.D., Yanaba K., Tedder T.F. Regulatory B cells as inhibitors of immune responses and inflammation. Immunol. Rev. 2008, 224:201-214.
12. Bouaziz J.D., Yanaba K., Venturi G.M., Wang Y., Tisch R.M., Poe J.C., Tedder T.F. Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice. Proc. Natl Acad. Sci. USA 2007, 104:20878-20883.
13. Constant S., Sant'Angelo D., Pasqualini T., Taylor T., Levin D., Flavell R., Bottomly K. Peptide and protein antigens require distinct antigen-presenting cell subsets for the priming of CD4+ T cells. J. Immunol. 1995, 154:4915-4923.
14. Crawford A., Macleod M., Schumacher T., Corlett L., Gray D. Primary T cell expansion and differentiation in vivo requires antigen presentation by B cells. J. Immunol. 2006, 176:3498-3506.
15. Cua D.J., Groux H., Hinton D.R., Stohlman S.A., Coffman R.L. Transgenic interleukin 10 prevents induction of experimental autoimmune encephalomyelitis. J. Exp. Med. 1999, 189:1005-1010.
16. Fillatreau S., Sweenie C.H., McGeachy M.J., Gray D., Anderton S.M. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 2002, 3:944-950.
17. Gigli G., Caielli S., Cutuli D., Falcone M. Innate immunity modulates autoimmunity: type 1 interferon-beta treatment in multiple sclerosis promotes growth and function of regulatory invariant natural killer T cells through dendritic cell maturation. Immunology 2007, 122:409-417.
18. Harris D.P., Haynes L., Sayles P.C., Duso D.K., Eaton S.M., Lepak N.M., Johnson L.L., Swain S.L., Lund F.E. Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat. Immunol. 2000, 1:475-482.
19. Hauser S.L., Waubant E., Arnold D.L., Vollmer T., Antel J., Fox R.J., Bar-Or A., Panzara M., Sarkar N., Agarwal S., Langer-Gould A., Smith C.H. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N Engl J. Med. 2008, 358:676-688.
20. Hellings N., Raus J., Stinissen P. Insights into the immunopathogenesis of multiple sclerosis. Immunol. Res. 2002, 25:27-51.
21. Ishikawa S., Sato T., Abe M., Nagai S., Onai N., Yoneyama H., Zhang Y., Suzuki T., Hashimoto S., Shirai T., Lipp M., Matsushima K. Aberrant high expression of B lymphocyte chemokine (BLC/CXCL13) by C11b+CD11c+ dendritic cells in murine lupus and preferential chemotaxis of B1 cells towards BLC. J. Exp. Med. 2001, 193:1393-1402.
22. Jee Y., Piao W.H., Liu R., Bai X.F., Rhodes S., Rodebaugh R., Campagnolo D.I., Shi F.D., Vollmer T.L. CD4(+)CD25(+) regulatory T cells contribute to the therapeutic effects of glatiramer acetate in experimental autoimmune encephalomyelitis. Clin. Immunol. 2007, 125:34-42.
23. Kala M., Rhodes S.N., Piao W.H., Shi F.D., Campagnolo D.I., Vollmer T.L. B cells from glatiramer acetate-treated mice suppress experimental autoimmune encephalomyelitis. Exp. Neurol. 2010, 221:136-145.
24. Karpus W.J., Swanborg R.H. CD4+ suppressor cells inhibit the function of effector cells of experimental autoimmune encephalomyelitis through a mechanism involving transforming growth factor-beta. J. Immunol. 1991, 146:1163-1168.
25. Kasper L.H., Haque A., Haque S. Regulatory mechanisms of the immune system in multiple sclerosis. Tregulatory cells: turned on to turn off. J. Neurol. 2007, 245S:10-14.
26. Kennedy M.K., Torrance D.S., Picha K.S., Mohler K.M. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J. Immunol. 1992, 149:2496-2505.
27. Linton P.J., Bautista B., Biederman E., Bradley E.S., Harbertson J., Kondrack R.M., Padrick R.C., Bradley L.M. Costimulation via OX40L expressed by B cells is sufficient to determine the extent of primary CD4 cell expansion and Th2 cytokine secretion in vivo. J. Exp. Med. 2003, 197:875-883.
28. Lund F.E., Garvy B.A., Randall T.D., Harris D.P. Regulatory roles for cytokine-producing B cells in infection and autoimmune disease. Curr. Dir. Autoimmun. 2005, 8:25-54.
29. Makar T.K., Bever C.T., Singh I.S., Royal W., Sahu S.N., Sura T.P., Sultana S., Sura K.T., Patel N., Dhib-Jalbut S., Trisler D. Brain-derived neurotrophic factor gene delivery in an animal model of multiple sclerosis using bone marrow stem cells as a vehicle. J. Neuroimmunol. 2009, 210:40-51.
30. Mann M.K., Maresz K., Shriver L.P., Tan Y., Dittel B.N. B cell regulation of CD4+CD25+ Tregulatory cells and IL-10 via B7 is essential for recovery from experimental autoimmune encephalomyelitis. J. Immunol. 2007, 178:3447-3456.
31. Matsushita T., Fujimoto M., Hasegawa M., Komura K., Takehara K., Tedder T.F., Sato S. Inhibitory role of CD19 in the progression of experimental autoimmune encephalomyelitis by regulating cytokine response. Am. J. Pathol. 2006, 168:812-821.
32. Matsushita T., Yanaba K., Bouaziz J.D., Fujimoto M., Tedder T.F. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J. Clin. Invest. 2008, 118:3420-3430.
33. Mills J.H., Thompson L.F., Mueller C., Waickman A.T., Jalkanen S., Niemela J., Airas L., Bynoe M.S. CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis. Proc. Natl Acad. Sci. USA 2008, 105:9325-9330.
34. Minns L.A., Menard L.C., Foureau D.M., Darche S., Ronet C., Mielcarz D.W., Buzoni-Gatel D., Kasper L.H. TLR9 is required for the gut-associated lymphoid tissue response following oral infection of Toxoplasma gondii. J. Immunol. 2006, 176:7589-7597.
35. O'Connor R.A., Prendergast C.T., Sabatos C.A., Lau C.W., Leech M.D., Wraith D.C., Anderton S.M. Cutting edge: Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis. J. Immunol. 2008, 181:3750-3754.
36. Ochoa-Reparaz J., Rynda A., Ascon M.A., Yang X., Kochetkova I., Riccardi C., Callis G., Trunkle T., Pascual D.W. IL-13 production by regulatory T cells protects against experimental autoimmune encephalomyelitis independently of autoantigen. J. Immunol. 2008, 181:954-968.
37. Riley C.P., Cope T.C., Buck C.R. CNS neurotrophins are biologically active and expressed by multiple cell types. J. Mol. Histol. 2004, 35:771-783.
38. Sinha S., Kaler L.J., Proctor T.M., Teuscher C., Vandenbark A.A., Offner H. IL-13-mediated gender difference in susceptibility to autoimmune encephalomyelitis. J. Immunol. 2008, 180:2679-2685.
39. Teitelbaum D., Aharoni R., Klinger E., Kreitman R., Raymond E., Malley A., Shofti R., Sela M., Arnon R. Oral glatiramer acetate in experimental autoimmune encephalomyelitis: clinical and immunological studies. Ann. NY Acad. Sci. 2004, 1029:239-249.
40. Thakker P., Leach M.W., Kuang W., Benoit S.E., Leonard J.P., Marusic S. IL-23 is critical in the induction but not in the effector phase of experimental autoimmune encephalomyelitis. J. Immunol. 2007, 178:2589-2598.
41. Wahl S.M. Transforming growth factor-beta: innately bipolar. Curr. Opin. Immunol. 2007, 19:55-62.
42. Weber M.S., Prod'homme T., Youssef S., Dunn S.E., Rundle C.D., Lee L., Patarroyo J.C., Stuve O., Sobel R.A., Steinman L., Zamvil S.S. Type II monocytes modulate T cell-mediated central nervous system autoimmune disease. Nat. Med. 2007, 13:935-943.
43. Wiesemann E., Deb M., Trebst C., Hemmer B., Stangel M., Windhagen A. Effects of interferon-beta on co-signaling molecules: upregulation of CD40, CD86 and PD-L2 on monocytes in relation to clinical response to interferon-beta treatment in patients with multiple sclerosis. Mult. Scler. 2008, 14:166-176.
44. Wolf S.D., Dittel B.N., Hardardottir F., Janeway C.A. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J. Exp. Med. 1996, 184:2271-2278.
45. Wurster A.L., Tanaka T., Grusby M.J. The biology of Stat4 and Stat6. Oncogene 2000, 19:2577-2584.
46. Xiu Y., Wong C.P., Bouaziz J.D., Hamaguchi Y., Wang Y., Pop S.M., Tisch R.M., Tedder T.F. B lymphocyte depletion by CD20 monoclonal antibody prevents diabetes in nonobese diabetic mice despite isotype-specific differences in Fc gamma R effector functions. J. Immunol. 2008, 180:2863-2875.
47. Yanaba K., Bouaziz J.D., Haas K.M., Poe J.C., Fujimoto M., Tedder T.F. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 2008, 28:639-650.
48. Young D.A., Lowe L.D., Booth S.S., Whitters M.J., Nicholson L., Kuchroo V.K., Collins M. IL-4, IL-10, IL-13, and TGF-beta from an altered peptide ligand-specific Th2 cell clone down-regulate adoptive transfer of experimental autoimmune encephalomyelitis. J. Immunol. 2000, 164:3563-3572.